New appointment at Premier Research Group
This article was originally published in Scrip
Premier Research Group (US) has appointed Dr Fabio Trave executive director of medical affairs and strategic product development. He will be based in the company's Milan office. Dr Trave has extensive experience working for both North American and European-based pharmaceutical companies, including Farmitalia Carlo Erba, Warner Lambert Parke-Davis, Pharmacia and Bristol-Myers Squibb, where he was most recently responsible for pharmacovigilance activities in Europe, Middle East, and Africa.
You may also be interested in...
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.